New hope for Tough-to-Treat bile duct cancer when standard therapy fails
NCT ID NCT04005339
Summary
This study is testing whether a combination of three chemotherapy drugs can help control advanced bile duct or gallbladder cancer that has worsened after initial treatment. It will involve about 48 adults whose cancer progressed despite standard chemotherapy. The main goal is to see if this new drug mix can stop the cancer from growing for at least four months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BILIARY TRACT CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10128, United States
-
Indiana University Health Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, 46202, United States
-
Lombardi Comprehensive Cancer Center, Georgetown University
Washington D.C., District of Columbia, 20007, United States
-
Washington University School of Medicine- Siteman Cancer Center
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.